Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel

Background. Tenofovir (TFV) gel partially protected against human immunodeficiency virus (HIV) in one but not subsequent trials. The disappointing results were attributed largely to poor adherence. However, timing of gel application relative to sex may impact pharmacokinetics and contribute to outco...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Herold, Betsy C., Chen, Beatrice A., Salata, Robert A., Marzinke, Mark A., Kelly, Clifton W., Dezzutti, Charlene S., McGowan, Ian, Galaska, Beth, Levy, Lisa, Piper, Jeanna M., Hillier, Sharon, Hendrix, Craig W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
HIV/AIDS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706638/
https://ncbi.nlm.nih.gov/pubmed/26508513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ913
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi